NCT06952660 2026-04-20Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical CancerPfizerPhase 4 Recruiting100 enrolled
NCT05237947 2026-04-13PRISMANational Cancer Institute (NCI)Phase 4 Active not recruiting5,000 enrolled